Equity
€97,764 ▲ 12.0%
Uvea paid out €45,891 in dividends. That is 81% of the 2025 profit.
Uvea
Lifetime
5 annual accounts with figures on one time axispeak €82,010 (2025)
€82,010▲ 19.6%
peak €56,399 (2025)
€56,399▲ 22.9%
peak €135,990 (2023)
€97,764▲ 12.0%
€12,402▼ 38.8%
Board1 name since 2020
1 director
Documentsfilings and deeds
21-05-202671 days before the deadline
2025micro format
Gross margin from €68,596 to €82,010Dividend €45,891Equity from €87,255 to €97,764Debts from €20,248 to €12,402
Key points
from the 2025 annual accountsTurnover
≈ €180,000 estimated
The micro format states no turnover.
Liquidity
8.72 was 4.88 in 2024
Short-term debts fell from €19,427 to €12,402.
Filings
5 annual accounts since 2021
The last five annual accounts were filed 32 to 97 days before the end of the period.
Starting capital
€3,000 3,000 shares
Position in the sector
88.7%
Higher solvency than 81% of companies in human health. Sector median 63.1% · 21,330 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 26,973 companies had the same profile as Uvea has now. Each dot stands for 68 companies, two years later.
94.8%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 26,973 companies, not a prediction for Uvea. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0751577675
Incorporation
Founding capital of €3,000, 3,000 shares · Founder: · Appointment: (director) · published on 31-07-2020 · Gazette deed
First establishment
Denneboomweg 1, Tienen
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| Uvea Tienen | €110,165 | €82,010 | 88.7% | - |
| DOCTEUR JERRY COUSIN PEDIATRE Hoeilaart | €113,503 | €88,264 | 2.2% | - |
| MY DERMA CONSULT Merchtem | €110,790 | €81,209 | 54.9% | - |
| Dr. Darcis Dermatology Brussels | €100,949 | €80,010 | 65.6% | - |
| EAS-MED Anderlecht | €109,726 | €85,877 | 54.8% | - |
| Biondel Willebroek | €103,843 | €77,504 | 2.2% | - |
| DR. E. VANDER STICHELE, GERIATER Ghent | €108,726 | €88,880 | 4.6% | - |
These companies have the same main activity as Uvea: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €101,000 and €114,000, founded between 2019 and 2021.
Official details
Source: KBO- Status
- Active since 29-07-2020Normal situation
- Activity
- Specialist medical practiceNACE 86220and 1 other
- Establishment unit
- 2.305.817.5833300 Tienen, since 29-07-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 08-12-2025
Annual accounts 2025
- €110,165▲ 2.5%
- Filing
- Filed on 21-05-2026, 71 days before the end of the filing period
Insights on Uvea
Uvea files the micro format. That format states no turnover. The gross margin rose from €63,813 in 2021 to €82,010 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about Uvea
- What is the company number of Uvea?
- The company number of Uvea is 0751.577.675. The VAT number is the same number with BE in front: BE 0751.577.675.
- Where is Uvea based?
- The registered office is at Denneboomweg 1, 3300 Tienen.Company details
- What does Uvea do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of Uvea?
- Uvea is a private limited company (BV).
- When was Uvea founded?
- Uvea was founded on 29-07-2020.
- Is Uvea still active?
- Yes, Uvea is an active enterprise in the KBO register.
- What is the turnover of Uvea?
- The turnover in financial year 2025 is ≈ €180,000. This figure is estimated from the gross margin of €82,010 and 34 comparable companies (NACE 862). It probably lies between €140,000 and €220,000.Financials
- Is Uvea profitable?
- In financial year 2025, Uvea made a profit of €56,399.
- Where can I find the annual accounts of Uvea?
- Uvea filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of Uvea due?
- Uvea must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.